Related Experiment Video
Updated: Feb 27, 2026

Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Striatal cholinergic interneurons and Parkinson's disease
Asami Tanimura1, Tristano Pancani1, Sean Austin O Lim1
1Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
Cholinergic interneurons (ChIs) are vital for striatal function in action control. New research reveals how ChI dysfunction contributes to Parkinson's disease (PD) and suggests potential therapeutic strategies.
Area of Science:
- Neuroscience
- Basal Ganglia Research
- Cholinergic Signaling
Background:
- Giant, aspiny cholinergic interneurons (ChIs) are central to striatal circuits governing goal-directed actions and habits.
- Recent advancements in optogenetics and viral tracing have illuminated ChI roles in action selection and dopamine-cholinergic interactions.
Purpose of the Study:
- To review the current understanding of ChI function in striatal physiology.
- To examine how ChI function is altered in Parkinson's disease (PD).
- To discuss translational implications and future research directions.
Main Methods:
- Review of recent experimental approaches including optogenetics and monosynaptic rabies virus mapping.
- Analysis of studies investigating striatal circuitry and dopaminergic-cholinergic signaling.
- Synthesis of findings related to ChI dysfunction in basal ganglia disorders.
Main Results:
- ChIs play a critical role in regulating striatal activity for action control.
- Distorted ChI function is implicated in the pathophysiology of Parkinson's disease.
- Understanding ChI mechanisms offers insights into basal ganglia disorders.
Conclusions:
- ChIs are key regulators of striatal function, with their dysfunction contributing to PD.
- Further research into ChI physiology and pathology is crucial for developing effective PD treatments.
- Bridging current knowledge gaps in ChI function holds significant translational potential for neurological disorders.
More Related Videos
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Neural Regulation
EPS and iPS Cells in Disease Research
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Neurons: Neurotransmission